Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial

NCT01424865 · clinicaltrials.gov ↗

UNKNOWN

Status

1874

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

GENETIC: fluorescence in situ hybridization
OTHER: immunohistochemistry staining method
OTHER: immunologic technique
OTHER: laboratory biomarker analysis

Sponsor

NSABP Foundation Inc

Collaborators

[object Object]